IP Verse

Gip/Glp1 Agonist Compositions - EP3810201B9

PatentPatent Analysis

EP3810201

ELI LILLY
Application Number
EP19739766A
Filing Date
Jun 14, 2019
Status
Granted And Under Opposition
May 5, 2023
Grant Date
Aug 2, 2023
External Links
Slate, Register, Google Patents
Similar Patents facing opposition
EP2247558B2
EP3668568B1
EP3432949B1

Bibliography

The patent EP3810201B9 was granted to ELI Lilly on Aug 2, 2023 following the initial filing on Jun 14, 2019 under the application number EP19739766A . The current legal status of the patent is Granted And Under Opposition.

AI Generated Summary New

Patent Family

Patent Family

Patent Oppositions (7)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateOpposition Status

Get instant alerts for new oppositions and patent status changes

BULLE DRMar 7, 2024ADMISSIBLE
GALENICUM HEALTH SLUMar 7, 2024ADMISSIBLE
GENERICS UKMar 7, 2024ADMISSIBLE
ELKINGTON AND FIFEMar 6, 2024ADMISSIBLE
STRAWMANMar 6, 2024ADMISSIBLE
KRAUS & LEDERER PARTGMBBMar 5, 2024ADMISSIBLE
SANDOZFeb 23, 2024ADMISSIBLE

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history, including filings, correspondence, and decisions made by patent offices. These documents are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination. It also includes the oppositions documents filed against the patent.

  • Date

    Description

  • Get instant alerts for new documents